Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > KMT2C(Gene name) > Human
  • Add your favorite
  • KMT2C (Gene name),
  • Histone-lysine N-methyltransferase 2C (Protein name ),  KMT2C_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    KMT2C(HALR;KIAA1506;MLL3);
    Protein name:
    Histone-lysine N-methyltransferase 2C(Lysine N-methyltransferase 2C);
    Alternative:
    Myeloid/lymphoid or mixed-lineage leukemia protein 3;Homologous to ALR protein;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Component of the MLL2/3 complex (also named ASCOM complex), at least composed of KMT2D/MLL2 or KMT2C/MLL3, ASH2L, RBBP5, WDR5, NCOA6, DPY30, KDM6A, PAXIP1/PTIP, PAGR1 and alpha-and beta-tubulin. Interacts with histone H3.
    Function:
    Histone methyltransferase. Methylates 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. Central component of the MLL2/3 complex, a coactivator complex of nuclear receptors, involved in transcriptional coactivation. KMT2C/MLL3 may be a catalytic subunit of this complex. May be involved in leukemogenesis and developmental disorder.
    Subcellular Location:
    Nucleus
    Protein Attributes:
    Sequence length:
    4911
    Sequence:
    50:
    MSSEEDKSVE | QPQPPPPPPE | EPGAPAPSPA | AADKRPRGRP | RKDGASPFQR | 
    100:
    ARKKPRSRGK | TAVEDEDSMD | GLETTETETI | VETEIKEQSA | EEDAEAEVDN | 
    150:
    SKQLIPTLQR | SVSEESANSL | VSVGVEAKIS | EQLCAFCYCG | EKSSLGQGDL | 
    200:
    KQFRITPGFI | LPWRNQPSNK | KDIDDNSNGT | YEKMQNSAPR | KQRGQRKERS | 
    250:
    PQQNIVSCVS | VSTQTASDDQ | AGKLWDELSL | VGLPDAIDIQ | ALFDSTGTCW | 
    300:
    AHHRCVEWSL | GVCQMEEPLL | VNVDKAVVSG | STERCAFCKH | LGATIKCCEE | 
    350:
    KCTQMYHYPC | AAGAGTFQDF | SHIFLLCPEH | IDQAPERSKE | DANCAVCDSP | 
    400:
    GDLLDQFFCT | TCGQHYHGMC | LDIAVTPLKR | AGWQCPECKV | CQNCKQSGED | 
    450:
    SKMLVCDTCD | KGYHTFCLQP | VMKSVPTNGW | KCKNCRICIE | CGTRSSSQWH | 
    500:
    HNCLICDNCY | QQQDNLCPFC | GKCYHPELQK | DMLHCNMCKR | WVHLECDKPT | 
    550:
    DHELDTQLKE | EYICMYCKHL | GAEMDRLQPG | EEVEIAELTT | DYNNEMEVEG | 
    600:
    PEDQMVFSEQ | AANKDVNGQE | STPGIVPDAV | QVHTEEQQKS | HPSESLDTDS | 
    650:
    LLIAVSSQHT | VNTELEKQIS | NEVDSEDLKM | SSEVKHICGE | DQIEDKMEVT | 
    700:
    ENIEVVTHQI | TVQQEQLQLL | EEPETVVSRE | ESRPPKLVME | SVTLPLETLV | 
    750:
    SPHEESISLC | PEEQLVIERL | QGEKEQKENS | ELSTGLMDSE | MTPTIEGCVK | 
    800:
    DVSYQGGKSI | KLSSETESSF | SSSADISKAD | VSSSPTPSSD | LPSHDMLHNY | 
    850:
    PSALSSSAGN | IMPTTYISVT | PKIGMGKPAI | TKRKFSPGRP | RSKQGAWSTH | 
    900:
    NTVSPPSWSP | DISEGREIFK | PRQLPGSAIW | SIKVGRGSGF | PGKRRPRGAG | 
    950:
    LSGRGGRGRS | KLKSGIGAVV | LPGVSTADIS | SNKDDEENSM | HNTVVLFSSS | 
    1000:
    DKFTLNQDMC | VVCGSFGQGA | EGRLLACSQC | GQCYHPYCVS | IKITKVVLSK | 
    1050:
    GWRCLECTVC | EACGKATDPG | RLLLCDDCDI | SYHTYCLDPP | LQTVPKGGWK | 
    1100:
    CKWCVWCRHC | GATSAGLRCE | WQNNYTQCAP | CASLSSCPVC | YRNYREEDLI | 
    1150:
    LQCRQCDRWM | HAVCQNLNTE | EEVENVADIG | FDCSMCRPYM | PASNVPSSDC | 
    1200:
    CESSLVAQIV | TKVKELDPPK | TYTQDGVCLT | ESGMTQLQSL | TVTVPRRKRS | 
    1250:
    KPKLKLKIIN | QNSVAVLQTP | PDIQSEHSRD | GEMDDSREGE | LMDCDGKSES | 
    1300:
    SPEREAVDDE | TKGVEGTDGV | KKRKRKPYRP | GIGGFMVRQR | SRTGQGKTKR | 
    1350:
    SVIRKDSSGS | ISEQLPCRDD | GWSEQLPDTL | VDESVSVTES | TEKIKKRYRK | 
    1400:
    RKNKLEETFP | AYLQEAFFGK | DLLDTSRQSK | ISLDNLSEDG | AQLLYKTNMN | 
    1450:
    TGFLDPSLDP | LLSSSSAPTK | SGTHGPADDP | LADISEVLNT | DDDILGIISD | 
    1500:
    DLAKSVDHSD | IGPVTDDPSS | LPQPNVNQSS | RPLSEEQLDG | ILSPELDKMV | 
    1550:
    TDGAILGKLY | KIPELGGKDV | EDLFTAVLSP | ANTQPTPLPQ | PPPPTQLLPI | 
    1600:
    HNQDAFSRMP | LMNGLIGSSP | HLPHNSLPPG | SGLGTFSAIA | QSSYPDARDK | 
    1650:
    NSAFNPMASD | PNNSWTSSAP | TVEGENDTMS | NAQRSTLKWE | KEEALGEMAT | 
    1700:
    VAPVLYTNIN | FPNLKEEFPD | WTTRVKQIAK | LWRKASSQER | APYVQKARDN | 
    1750:
    RAALRINKVQ | MSNDSMKRQQ | QQDSIDPSSR | IDSELFKDPL | KQRESEHEQE | 
    1800:
    WKFRQQMRQK | SKQQAKIEAT | QKLEQVKNEQ | QQQQQQQFGS | QHLLVQSGSD | 
    1850:
    TPSSGIQSPL | TPQPGNGNMS | PAQSFHKELF | TKQPPSTPTS | TSSDDVFVKP | 
    1900:
    QAPPPPPAPS | RIPIQDSLSQ | AQTSQPPSPQ | VFSPGSSNSR | PPSPMDPYAK | 
    1950:
    MVGTPRPPPV | GHSFSRRNSA | APVENCTPLS | SVSRPLQMNE | TTANRPSPVR | 
    2000:
    DLCSSSTTNN | DPYAKPPDTP | RPVMTDQFPK | SLGLSRSPVV | SEQTAKGPIA | 
    2050:
    AGTSDHFTKP | SPRADVFQRQ | RIPDSYARPL | LTPAPLDSGP | GPFKTPMQPP | 
    2100:
    PSSQDPYGSV | SQASRRLSVD | PYERPALTPR | PIDNFSHNQS | NDPYSQPPLT | 
    2150:
    PHPAVNESFA | HPSRAFSQPG | TISRPTSQDP | YSQPPGTPRP | VVDSYSQSSG | 
    2200:
    TARSNTDPYS | QPPGTPRPTT | VDPYSQQPQT | PRPSTQTDLF | VTPVTNQRHS | 
    2250:
    DPYAHPPGTP | RPGISVPYSQ | PPATPRPRIS | EGFTRSSMTR | PVLMPNQDPF | 
    2300:
    LQAAQNRGPA | LPGPLVRPPD | TCSQTPRPPG | PGLSDTFSRV | SPSAARDPYD | 
    2350:
    QSPMTPRSQS | DSFGTSQTAH | DVADQPRPGS | EGSFCASSNS | PMHSQGQQFS | 
    2400:
    GVSQLPGPVP | TSGVTDTQNT | VNMAQADTEK | LRQRQKLREI | ILQQQQQKKI | 
    2450:
    AGRQEKGSQD | SPAVPHPGPL | QHWQPENVNQ | AFTRPPPPYP | GNIRSPVAPP | 
    2500:
    LGPRYAVFPK | DQRGPYPPDV | ASMGMRPHGF | RFGFPGGSHG | TMPSQERFLV | 
    2550:
    PPQQIQGSGV | SPQLRRSVSV | DMPRPLNNSQ | MNNPVGLPQH | FSPQSLPVQQ | 
    2600:
    HNILGQAYIE | LRHRAPDGRQ | RLPFSAPPGS | VVEASSNLRH | GNFIPRPDFP | 
    2650:
    GPRHTDPMRR | PPQGLPNQLP | VHPDLEQVPP | SQQEQGHSVH | SSSMVMRTLN | 
    2700:
    HPLGGEFSEA | PLSTSVPSET | TSDNLQITTQ | PSDGLEEKLD | SDDPSVKELD | 
    2750:
    VKDLEGVEVK | DLDDEDLENL | NLDTEDGKVV | ELDTLDNLET | NDPNLDDLLR | 
    2800:
    SGEFDIIAYT | DPELDMGDKK | SMFNEELDLP | IDDKLDNQCV | SVEPKKKEQE | 
    2850:
    NKTLVLSDKH | SPQKKSTVTN | EVKTEVLSPN | SKVESKCETE | KNDENKDNVD | 
    2900:
    TPCSQASAHS | DLNDGEKTSL | HPCDPDLFEK | RTNRETAGPS | ANVIQASTQL | 
    2950:
    PAQDVINSCG | ITGSTPVLSS | LLANEKSDNS | DIRPSGSPPP | PTLPASPSNH | 
    3000:
    VSSLPPFIAP | PGRVLDNAMN | SNVTVVSRVN | HVFSQGVQVN | PGLIPGQSTV | 
    3050:
    NHSLGTGKPA | TQTGPQTSQS | GTSSMSGPQQ | LMIPQTLAQQ | NRERPLLLEE | 
    3100:
    QPLLLQDLLD | QERQEQQQQR | QMQAMIRQRS | EPFFPNIDFD | AITDPIMKAK | 
    3150:
    MVALKGINKV | MAQNNLGMPP | MVMSRFPFMG | QVVTGTQNSE | GQNLGPQAIP | 
    3200:
    QDGSITHQIS | RPNPPNFGPG | FVNDSQRKQY | EEWLQETQQL | LQMQQKYLEE | 
    3250:
    QIGAHRKSKK | ALSAKQRTAK | KAGREFPEED | AEQLKHVTEQ | QSMVQKQLEQ | 
    3300:
    IRKQQKEHAE | LIEDYRIKQQ | QQCAMAPPTM | MPSVQPQPPL | IPGATPPTMS | 
    3350:
    QPTFPMVPQQ | LQHQQHTTVI | SGHTSPVRMP | SLPGWQPNSA | PAHLPLNPPR | 
    3400:
    IQPPIAQLPI | KTCTPAPGTV | SNANPQSGPP | PRVEFDDNNP | FSESFQERER | 
    3450:
    KERLREQQER | QRIQLMQEVD | RQRALQQRME | MEQHGMVGSE | ISSSRTSVSQ | 
    3500:
    IPFYSSDLPC | DFMQPLGPLQ | QSPQHQQQMG | QVLQQQNIQQ | GSINSPSTQT | 
    3550:
    FMQTNERRQV | GPPSFVPDSP | SIPVGSPNFS | SVKQGHGNLS | GTSFQQSPVR | 
    3600:
    PSFTPALPAA | PPVANSSLPC | GQDSTITHGH | SYPGSTQSLI | QLYSDIIPEE | 
    3650:
    KGKKKRTRKK | KRDDDAESTK | APSTPHSDIT | APPTPGISET | TSTPAVSTPS | 
    3700:
    ELPQQADQES | VEPVGPSTPN | MAAGQLCTEL | ENKLPNSDFS | QATPNQQTYA | 
    3750:
    NSEVDKLSME | TPAKTEEIKL | EKAETESCPG | QEEPKLEEQN | GSKVEGNAVA | 
    3800:
    CPVSSAQSPP | HSAGAPAAKG | DSGNELLKHL | LKNKKSSSLL | NQKPEGSICS | 
    3850:
    EDDCTKDNKL | VEKQNPAEGL | QTLGAQMQGG | FGCGNQLPKT | DGGSETKKQR | 
    3900:
    SKRTQRTGEK | AAPRSKKRKK | DEEEKQAMYS | STDTFTHLKQ | QNNLSNPPTP | 
    3950:
    PASLPPTPPP | MACQKMANGF | ATTEELAGKA | GVLVSHEVTK | TLGPKPFQLP | 
    4000:
    FRPQDDLLAR | ALAQGPKTVD | VPASLPTPPH | NNQEELRIQD | HCGDRDTPDS | 
    4050:
    FVPSSSPESV | VGVEVSRYPD | LSLVKEEPPE | PVPSPIIPIL | PSTAGKSSES | 
    4100:
    RRNDIKTEPG | TLYFASPFGP | SPNGPRSGLI | SVAITLHPTA | AENISSVVAA | 
    4150:
    FSDLLHVRIP | NSYEVSSAPD | VPSMGLVSSH | RINPGLEYRQ | HLLLRGPPPG | 
    4200:
    SANPPRLVSS | YRLKQPNVPF | PPTSNGLSGY | KDSSHGIAES | AALRPQWCCH | 
    4250:
    CKVVILGSGV | RKSFKDLTLL | NKDSRESTKR | VEKDIVFCSN | NCFILYSSTA | 
    4300:
    QAKNSENKES | IPSLPQSPMR | ETPSKAFHQY | SNNISTLDVH | CLPQLPEKAS | 
    4350:
    PPASPPIAFP | PAFEAAQVEA | KPDELKVTVK | LKPRLRAVHG | GFEDCRPLNK | 
    4400:
    KWRGMKWKKW | SIHIVIPKGT | FKPPCEDEID | EFLKKLGTSL | KPDPVPKDYR | 
    4450:
    KCCFCHEEGD | GLTDGPARLL | NLDLDLWVHL | NCALWSTEVY | ETQAGALINV | 
    4500:
    ELALRRGLQM | KCVFCHKTGA | TSGCHRFRCT | NIYHFTCAIK | AQCMFFKDKT | 
    4550:
    MLCPMHKPKG | IHEQELSYFA | VFRRVYVQRD | EVRQIASIVQ | RGERDHTFRV | 
    4600:
    GSLIFHTIGQ | LLPQQMQAFH | SPKALFPVGY | EASRLYWSTR | YANRRCRYLC | 
    4650:
    SIEEKDGRPV | FVIRIVEQGH | EDLVLSDISP | KGVWDKILEP | VACVRKKSEM | 
    4700:
    LQLFPAYLKG | EDLFGLTVSA | VARIAESLPG | VEACENYTFR | YGRNPLMELP | 
    4750:
    LAVNPTGCAR | SEPKMSAHVK | RFVLRPHTLN | STSTSKSFQS | TVTGELNAPY | 
    4800:
    SKQFVHSKSS | QYRKMKTEWK | SNVYLARSRI | QGLGLYAARD | IEKHTMVIEY | 
    4850:
    IGTIIRNEVA | NRKEKLYESQ | NRGVYMFRMD | NDHVIDATLT | GGPARYINHS | 
    4900:
    CAPNCVAEVV | TFERGHKIII | SSSRRIQKGE | ELCYDYKFDF | EDDQHKIPCH | 
    4911:
    CGAVNCRKWM | N
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    SMR:
    Pfam:
    KEGG:
    UniGene:
    MIM:
    Uniprot:
     
    FOR
    ELISA Kit for Human Lysine N-methyltransferase 2C
    ELISA Kit for Human Lysine N-methyltransferase 2C
    CLIA Kit for Human Lysine N-methyltransferase 2C
    CLIA Kit for Human Lysine N-methyltransferase 2C
    Polyclonal Antibody for Human Lysine N-methyltransferase 2C
    Polyclonal Antibody for Human Lysine N-methyltransferase 2C
    Monoclonal Antibody for Human Lysine N-methyltransferase 2C
    Monoclonal Antibody for Human Lysine N-methyltransferase 2C
    Protein for Human Lysine N-methyltransferase 2C
    Protein for Human Lysine N-methyltransferase 2C

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "MLL3, a new human member of the TRX/MLL gene family, maps to 7q36, a chromosome region frequently deleted in myeloid leukaemia."
      Ruault M. , Brun M.-E. , Ventura M. , Roizes G. , De Sario A.
      Gene284:73-81(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);VARIANT PRO-526
      tissue: Fetal thymus.
    2. 2.
      "Novel human HALR (MLL3) gene encodes a protein homologous to ALR and to ALL-1 involved in leukemia, and maps to chromosome 7q36 associated with leukemia and developmental defects."
      Tan Y.C. , Chow V.T.
      Cancer Detect. Prev.25:454-469(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)
      tissue: Cervix carcinoma.
    3. 3.
      "The DNA sequence of human chromosome 7."
      Hillier L.W. , Fulton R.S. , Fulton L.A. , Graves T.A. , Pepin K.H. , Wagner-McPherson C. , Layman D. , Maas J. , Jaeger S. , Walker R. , Wylie K. , Sekhon M. , Becker M.C. , O'Laughlin M.D. , Schaller M.E. , Fewell G.A. , Delehaunty K.D. , Miner T.L. , more...
      Nature424:157-164(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    4. 4.
      "Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro."
      Nagase T. , Kikuno R. , Ishikawa K. , Hirosawa M. , Ohara O.
      DNA Res.7:143-150(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 556-3865 (ISOFORM 1)
      tissue: Brain.
    5. 5.
      "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones."
      Nakajima D. , Okazaki N. , Yamakawa H. , Kikuno R. , Ohara O. , Nagase T.
      DNA Res.9:99-106(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: SEQUENCE REVISION
    6. 6.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3193-3865 AND 4460-4911
      tissue: Placenta.
    7. 7.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)
      tissue: Testis.
    8. 8.
      "Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins."
      Goo Y.-H. , Sohn Y.C. , Kim D.-H. , Kim S.-W. , Kang M.-J. , Jung D.-J. , Kwak E. , Barlev N.A. , Berger S.L. , Chow V.T. , Roeder R.G. , Azorsa D.O. , Meltzer P.S. , Suh P.-G. , Song E.J. , Lee K.-J. , Lee Y.C. , Lee J.W.
      Mol. Cell. Biol.23:140-149(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH MLL2/3 COMPLEX (ISOFORM 2)
      tissue: Cervix carcinoma.
    9. 9.
      "Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases."
      Lee S. , Lee D.K. , Dou Y. , Lee J. , Lee B. , Kwak E. , Kong Y.Y. , Lee S.K. , Roeder R.G. , Lee J.W.
      Proc. Natl. Acad. Sci. U.S.A.103:15392-15397(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION IN THE MLL2/3 (ASCOM) COMPLEX
    10. 10.
      "PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex."
      Cho Y.-W. , Hong T. , Hong S. , Guo H. , Yu H. , Kim D. , Guszczynski T. , Dressler G.R. , Copeland T.D. , Kalkum M. , Ge K.
      J. Biol. Chem.282:20395-20406(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;ENZYME ACTIVITY;IDENTIFICATION BY MASS SPECTROMETRY;IDENTIFICATION IN THE MLL2/3 COMPLEX
    11. 11.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    12. 12.
      "Lysine acetylation targets protein complexes and co-regulates major cellular functions."
      Choudhary C. , Kumar C. , Gnad F. , Nielsen M.L. , Rehman M. , Walther T.C. , Olsen J.V. , Mann M.
      Science325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-758; LYS-1508; LYS-1772; LYS-2009; LYS-2802; LYS-2809; LYS-2832 AND LYS-3714;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    13. 13.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    14. 14.
      "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
      Rigbolt K.T. , Prokhorova T.A. , Akimov V. , Henningsen J. , Johansen P.T. , Kratchmarova I. , Kassem M. , Mann M. , Olsen J.V. , Blagoev B.
      Sci. Signal.4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89 AND SER-1301;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    15. 15.
      "Solution structure of the first and second PHD domain from myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog."
      RIKEN structural genomics initiative (RSGI)
      Submitted (2007-10) to the PDB data bank
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 342-439
    16. 16.
      "Solution structure of the HMG box of human myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog."
      RIKEN structural genomics initiative (RSGI)
      Submitted (2008-04) to the PDB data bank
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: STRUCTURE BY NMR OF 1624-1713
    17. 17.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS [LARGE SCALE ANALYSIS] GLY-347; ASN-400; TRP-478 AND SER-3698
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter